Abstract
THE idea that the “pink spot” is uniquely associated with schizophrenia1–3 is now in doubt because of its reported presence in normal individuals4,5 and in patients suffering from Parkinson's disease6. Additionally, some doubt must be cast on its identification as β-3,4-dimethoxyphenylethylamine (DMPE)1,7. The evidence supporting the finding that the “pink spot” is DMPE rests on its almost exact correspondence with DMPE in certain paper chromatographic1,4,7 and gas chromatographic8,9 systems, the chromatographic similarity of prepared derivatives1,7 and the similarity of the melting point range of the hydrochlorides22. This indirect identification of the “pink spot” as DMPE is of great interest because of the hypothesis10,11 that in schizophrenia abnormal methylation of catecholamines might occur. This hypothesis is strengthened by the chemical similarity between DMPE and the halucinogenic substance mescaline and also by the observation that the feeding of substances capable of donating a methyl group can cause an exacerbation of schizophrenic symptoms12–14.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Friedhoff, A. J., and van Winkle, E., Nature, 194, 897 (1962).
Kuehl, F. A., Hichens, M., Ormond, R. E., Meisinger, M. A. P., Gale, P. H., Cirillo, V. J., and Brink, N. G., Nature, 203, 154 (1964).
Bourdillon, R. E., Clarke, C. A., Ridges, A. P., Sheppard, P. M., Harper, P., and Leslie, S. A., Nature, 208, 453 (1965).
Takesada, M., Kakimoto, Y., Sano, I., and Kaneko, Z., Nature, 199, 203 (1963)
von Studnitz, W., and Nyman, G. E., Acta Psychiat. Scand., 41, 117 (1965).
Barbeau, A., de Groot, J. A., Joly, J. G., Tremblay, D. R., and Donaldson, J., Rev. Canad. Biol., 22, 469 (1963).
Friedhoff, A. J., and van Winkle, E., J. Nerv. Ment. Dis., 135, 550 (1962).
Sen, N. P., and McGeer, P. L., Biochem. Biophys. Res. Commun., 14, 227 (1964).
Friedhoff, A. J. (personal communication).
Osmond, H., and Smythies, J., J. Ment. Sci., 98, 309 (1952).
Harley-Mason, J., J. Ment. Sci., 98, 313 (1952).
Park, L. C., Baldessarini, R. J., and Kety, S. S., Arch. Gen. Psychiat., 12, 346 (1965).
Pollin, W., Cardon, P. V., and Kety, S. S., Science, 133, 104 (1961).
Brune, C. G., and Himwich, H. E., J. Nerv. Ment. Dis., 134, 447 (1962).
Friedhoff, A. J., and van Winkle, E., J. Chromatog., 11, 272 (1963).
Faurbye, A., and Pind, K., Acta. Psychiat. Scand., 40, 240 (1964).
Seiler, N., and Weichmann, M., Hoppe-Seyl. Z., 337, 229 (1964).
Bell, C. E., and Somerville, A. R., Biochem. J., 98, 1c (1966).
Boulton, A. A., Chard, N. E., and Grant, L., Biochem. J., 96, 83P (1965).
Pind, K., and Faurbye, A., Acta Psychiat. Scand. (in the press).
Perry, T. L., Hestrin, M., MacDougall, L., and Hansen, S., Clin. Chim. Acta, 14, 116 (1966).
Friedhoff, A. J., and van Winkle, E., Nature, 202, 520 (1964).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
BOULTON, A., FELTON, C. The “Pink Spot” and Schizophrenia. Nature 211, 1404–1405 (1966). https://doi.org/10.1038/2111404a0
Issue Date:
DOI: https://doi.org/10.1038/2111404a0
This article is cited by
-
Biochemical Research in Schizophrenia
Nature (1971)
-
Nor2Chlorpromazine Sulphoxide and 3,4-Dimethoxyphenethylamine
Nature (1968)
-
Pink Spot as a Diagnostic Test in Schizophrenia
Nature (1968)
-
Urinary Metabolites in Parkinson's Disease
Nature (1968)
-
Identity of a Urinary “Pink Spot” in Schizophrenia and Parkinson's Disease
Nature (1967)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.
